| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +6.2% |
| R&D Expense | $0 | -100.0% |
| Operating Income | -$4.9M | +68.7% |
| Interest Expense | $325K | +94.8% |
| Pre-tax Income | -$7.9M | +52.7% |
| Net Income | -$7.9M | +52.7% |
| EPS (Basic) | -$8.44 | -430.8% |
| EPS (Diluted) | -$8.44 | -430.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.9M | +900.8% |
| Accounts Receivable | $81K | -59.1% |
| Current Assets | $3.2M | +280.4% |
| Total Assets | $21.0M | +2.0% |
| Current Liabilities | $13.9M | +105.3% |
| Total Liabilities | $13.9M | +5.1% |
| Stockholders' Equity | $7.1M | -3.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | +23.6% |
| Capital Expenditures | $22K | +0.0% |
| Investing Cash Flow | -$100K | -351.3% |
| Financing Cash Flow | $7.6M | +58.3% |
| Free Cash Flow | -$5.0M | +23.5% |